Pikralida is a biotechnology company that researches and produces medicines.
Pikralida has raised $3.4M in total funding. The most recent round was Seed. The last funding was announced in November 2025.
Pikralida's investors include Altamira, Hard2beat, iif.vc, N50/Manawa, Stanislaw Pikul.
Pikralida is headquartered in Poznan, Poland.
Pikralida is a biotechnology company that researches and produces medicines.
Pikralida is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Pikralida — Funding & Investors." VCBacked, November 22, 2025, https://www.vcbacked.co/company/pikralida. Accessed September 30, 2026.
VCBacked. (2025). Pikralida — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/pikralida
{{cite web |title=Pikralida — Funding & Investors |url=https://www.vcbacked.co/company/pikralida |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated